Soleno Therapeutics Wins FDA Approval for VYKAT XR to Treat Hyperphagia in Prader-Willi Syndrome Read more
Novo Holdings Joins €23M Series A for Tribune Therapeutics to Advance Anti-Fibrotic Therapies Read more